Stocks
Amedisys Financial Statements (AMED) |
||||||||||
| Amedisyssmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 24.02.2022 | 31.12.2022 | 16.02.2023 | 22.02.2024 | 26.04.2024 | 07.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 2 214 | 2 223 | 2 223 | 2 236 | 2 236 | 2 341 | |||
| Operating Income, bln rub | 251.9 | 180.8 | 180.8 | 193.1 | 156.4 | 180.7 | ||||
| EBITDA, bln rub | ? | 320.7 | 183.5 | 207.4 | 216.9 | 216.9 | 185.5 | |||
| Net profit, bln rub | ? | 209.1 | 118.6 | 118.6 | -9.75 | -9.75 | 179.0 | |||
| OCF, bln rub | ? | 188.9 | 133.3 | 133.3 | 137.2 | 137.2 | 270.5 | |||
| CAPEX, bln rub | ? | 6.72 | 6.17 | 7.22 | 12.7 | 12.7 | 6.45 | |||
| FCF, bln rub | ? | 182.2 | 127.1 | 126.1 | 124.5 | 124.5 | 264.1 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 25.7 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 14.4% | ||||
| OPEX, bln rub | 728.8 | 2 042 | 779.0 | 264.0 | 264.0 | 1 700 | ||||
| Cost of production, bln rub | 1 233 | 0.000 | 1 260 | 1 779 | 1 779 | 865.4 | ||||
| R&D, bln rub | 0.000 | 0.000 | 3.00 | 3.80 | 3.80 | 3.80 | ||||
| Interest expenses, bln rub | 9.53 | 22.2 | 22.2 | 31.3 | 31.3 | 31.8 | ||||
| Assets, bln rub | 1 857 | 1 976 | 1 976 | 2 060 | 2 060 | 2 139 | ||||
| Net Assets, bln rub | ? | 931.4 | 1 052 | 1 052 | 1 067 | 1 067 | 1 148 | |||
| Debt, bln rub | 545.6 | 542.7 | 537.9 | 487.2 | 487.2 | 468.6 | ||||
| Cash, bln rub | 42.7 | 40.5 | 40.5 | 145.9 | 126.5 | 245.5 | ||||
| Net debt, bln rub | 502.9 | 502.2 | 497.4 | 341.4 | 360.8 | 223.1 | ||||
| Ordinary share price, rub | 161.9 | 83.5 | 83.5 | 95.1 | 95.1 | 91.4 | ||||
| Number of ordinary shares, mln | 32.6 | 32.6 | 32.5 | 32.6 | 32.5 | 32.7 | ||||
| Market cap, bln rub | 5 284 | 2 720 | 2 716 | 3 099 | 3 088 | 2 993 | ||||
| EV, bln rub | ? | 5 787 | 3 222 | 3 214 | 3 440 | 3 449 | 3 216 | |||
| Book value, bln rub | -376 | -337 | -337 | -281 | -281 | -197 | ||||
| EPS, rub | ? | 6.40 | 3.64 | 3.65 | -0.30 | -0.30 | 5.47 | |||
| FCF/share, rub | 5.58 | 3.90 | 3.88 | 3.82 | 3.83 | 8.07 | ||||
| BV/share, rub | -11.5 | -10.4 | -10.4 | -8.61 | -8.64 | -6.00 | ||||
| EBITDA margin, % | ? | 14.5% | 8.25% | 9.33% | 9.70% | 9.70% | 7.92% | |||
| Net margin, % | ? | 9.44% | 5.34% | 5.34% | -0.44% | -0.44% | 7.65% | |||
| FCF yield, % | ? | 3.45% | 4.67% | 4.64% | 4.02% | 4.03% | 8.82% | |||
| ROE, % | ? | 22.4% | 11.3% | 11.3% | -0.91% | -0.91% | 15.6% | |||
| ROA, % | ? | 11.3% | 6.00% | 6.00% | -0.47% | -0.47% | 8.37% | |||
| P/E | ? | 25.3 | 22.9 | 22.9 | -317.9 | -316.9 | 16.7 | |||
| P/FCF | 29.0 | 21.4 | 21.5 | 24.9 | 24.8 | 11.3 | ||||
| P/S | ? | 2.39 | 1.22 | 1.22 | 1.39 | 1.38 | 1.28 | |||
| P/BV | ? | -14.1 | -8.07 | -8.06 | -11.0 | -11.0 | -15.2 | |||
| EV/EBITDA | ? | 18.0 | 17.6 | 15.5 | 15.9 | 15.9 | 17.3 | |||
| Debt/EBITDA | 1.57 | 2.74 | 2.40 | 1.57 | 1.66 | 1.20 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 41.6% | 29.9% | 29.9% | 59.0% | ||||
| CAPEX/Revenue, % | 0.30% | 0.28% | 0.32% | 0.57% | 0.57% | 0.28% | ||||
| Amedisys shareholders | ||||||||||
